FUL — FULLER H B CO
—
NYSE ·
Materials ·
Chemicals ·
CIK 39368 ·
Last close
$55.91
Market Cap
$3.01B
52W High
$66.45
52W Low
$54.76
ADV30
919,193
Next earnings
2026-09-23
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| May 2026 | 950,271,000 | 319,654,000 | 117,289,000 | 67,805,000 | 5,328,793,000 | 114,102,000 | 3,246,329,000 |
| Feb 2026 | 770,844,000 | 236,048,000 | 51,598,000 | 21,045,000 | 5,220,297,000 | 107,877,000 | 3,154,992,000 |
| Nov 2025 | 894,788,000 | 282,082,000 | 121,251,000 | 29,731,000 | 5,182,706,000 | 107,213,000 | 3,179,512,000 |
| Aug 2025 | 892,043,000 | 285,114,000 | 110,140,000 | 67,160,000 | 5,166,102,000 | 122,458,000 | 3,207,130,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$322,893,000
Investing CF
$-191,898,000
Financing CF
$-129,523,000
CapEx
$-182,121,000
Dividends Paid
$-51,377,000
Buybacks
$-48,820,000
EPS Diluted TTM
$3.37
As of
2026-06-28
Balance + Analyst (yfinance extras)
Retained Earnings
$2,088,749,000
Inventory
$526,737,000
Receivables
$622,745,000
ST Investments
—
EBIT TTM
$375,269,000
Pretax Income TTM
$243,202,000
Interest Exp TTM
$132,067,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,507,945,984
EBITDA
$605,875,968
Free Cash Flow
$219,408,128
Enterprise Value
$5,062,247,424
Total Cash
$114,102,000
Total Debt
$2,212,663,040
Shares Out
53,787,411
Trailing EPS
$3.37
Book Value
$38.72
ROE
9.4%
ROA
5.0%
Div Yield
1.78%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Nov 2025 | 3,473,589,000 | 377,882,000 | 151,967,000 | 5,182,706,000 | 3,179,512,000 | — | 263,493,000 |
| Nov 2024 | 3,568,736,000 | 364,140,000 | 130,256,000 | 4,933,244,000 | 3,103,396,000 | — | 302,437,000 |
| Nov 2023 | 3,510,934,000 | 375,383,000 | 144,906,000 | 4,723,575,000 | 2,967,662,000 | — | 378,398,000 |
| Nov 2022 | 3,749,183,000 | 349,505,000 | 180,313,000 | 4,463,629,000 | 2,852,835,000 | — | 256,514,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$5.32
Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)
max pain strike: $65.00 · spot: $55.91 · call volume: 126 · put volume: 14Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RGC | Regencell Bioscience Holdings Ltd | $2.91B | $5.88 | — |
| AVNT | AVIENT CORP | $3.30B | $36.03 | — |
| CC | Chemours Co | $2.68B | $17.81 | — |
| WDFC | WD 40 CO | $3.56B | $264.91 | — |
| NGVT | Ingevity Corp | $2.51B | $72.07 | — |
News headlines (Yahoo Finance, 1h cache)
Should Value Investors Buy H. B. Fuller (FUL) Stock?
2026-07-10 13:40 · Yahoo
FUL Stock Is Riding Medical, Aerospace and Pricing Trends
2026-07-09 12:09 · Yahoo
H.B. Fuller Stock Outlook Hinges on Margins, Mix and M&A
2026-07-09 12:04 · Yahoo
Is FUL Stock a Buy Now or a Value Trap for Cautious Investors?
2026-07-09 12:02 · Yahoo
Who Is the Right Buyer for Specialty Chemicals Maker Innospec?
2026-07-08 11:38 · Yahoo
FUL vs. PPG: Which Stock Is the Better Value Option?
2026-07-06 15:40 · Yahoo
H.B. Fuller Q2 Earnings Call Flags Pricing, AMS Ambitions
2026-06-30 08:22 · Yahoo
H.B. Fuller Co (FUL) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
2026-06-25 23:00 · Yahoo
H.B. Fuller (FUL) Stock After Recent 17% Gain Is The Valuation Still Reasonable
2026-06-25 16:09 · Yahoo
Ancora Condemns H.B. Fuller’s Decision to Ignore Shareholder Opposition and Proceed with the Reckless Acquisition of Advanced Medical Solutions
2026-06-25 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.